Yahoo Web Search

  1. Hill-Rom (HRC) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank. Arguably nothing ...

  2. One of these stocks was Hill-Rom Holdings, Inc. (NYSE:HRC). Is Hill-Rom Holdings, Inc. (NYSE:HRC) ready to rally soon? HRC was in 27 hedge funds' portfolios ...

  3. A look at the shareholders of Hill-Rom Holdings, Inc. (NYSE:HRC) can tell us which group is most powerful. Large companies usually have institutions as shareholders, and ...

  4. Medtronic plc MDT recently obtained the Breakthrough Device designation from the FDA for its Valiant TAAA Stent Graft System, designed for the minimally invasive repair of thoracoabdominal aortic ...

  5. Here's Why You Should Hold on to Teleflex (TFX) Stock Now

    Zacks via Yahoo FinanceOct 09 11:50 AM

    This is also expected to keep contributing to the company's top line through the year. Favorable Study Outcome: In August 2019, the company announced favorable results from its SAFE MANTA IDE ...

  6. HRC or BAX: Which Is the Better Value Stock Right Now?

    Zacks via Yahoo FinanceOct 10 13:30 PM

    Products sector have probably already heard of Hill-Rom (HRC) and Baxter International (BAX). We have found that the best way to discover great value opportunities is to pair a ...

  7. The stock has a Zacks Rank #2 (Buy). Over the past year, Thermo Fisher has successfully outperformed its industry. The stock has rallied 18.2% compared with the industry's 0.8% rise.

  8. If the dismal preliminary sales performance was not enough, then the news pertaining to QIAGEN's (QGEN) current CEO Peer M. Schatz's stepping down came as another huge blow.

  9. Smith & Nephew's (SNN) STITCH Study Outcome Encouraging

    Zacks via Yahoo FinanceOct 10 14:07 PM

    Smith & Nephewplc SNN recently announced favorable one-year results of the STITCH Study evaluating its NOVOSTITCH Meniscal Repair System. This can be considered a major step toward the company's ...

  10. Align Technology's steady momentum in Invisalign volumes across all geographies and solid worldwide volume growth for teenage patient cases buoy optimism on the stock. A solid performance in ...